893
Participants
Start Date
September 30, 2009
Primary Completion Date
January 4, 2013
Study Completion Date
January 4, 2013
Advagraf
Capsule
Mycophenolate Mofetil
Solution for infusion
Basiliximab
IV infusion
Corticosteroids
IV bolus
070, Dublin
026, Helsinki
074, Rome
008, Brussels
061, Budapest
087, Warsaw
009, Leuven
010, Liège
054, Leipzig
001, Innsbruck
110, Barcelona
131, Zurich
006, Ghent
056, Berlin
045, Marseille
147, Prague
043, Caen
114, A Coruña
076, Genova
091, Bucharest
053, Kiel
073, Bergamo
041, Besançon
115, Madrid
108, Madrid
117, Madrid
057, Hanover
033, Toulouse
157, Bordeaux
071, Udine
158, Montpelier
072, Padua
055, Göttingen
075, Bologna
126, Gothenberg
052, Münster
116, Zaragoza
051, Frankfurt
038, Strasbourg
039, Lyon
059, Tübingen
042, Paris
044, Paris
077, Naples
079, Naples
058, Erlangen
035, Paris
060, Regensberg
031, Créteil
034, Villejuif
096, Moscow
097, Moscow
146, Minsk
160, Buenos Aires
163, São Paulo
169, Bogata
Site: 156, Mainz
Site: 166, Mexico City
148, Johannesburg
153, Edmonton
150, Halifax
151, London
152, Montreal
154, Vancouver
037, Nice
142, Jena
086, Warsaw
109, Barcelona
106, Barcelona
136, Birmingham
171, Leeds
138, London
Lead Sponsor
Astellas Pharma Inc
INDUSTRY